Why hasn't my sleep returned to normal after discontinuing aripiprazole (Abilify) following long-term use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Persistent Sleep Disturbance After Aripiprazole Discontinuation

Your persistent sleep problems after stopping aripiprazole, even years later, are likely not directly caused by the medication itself but rather represent either unmasked chronic insomnia disorder or a separate sleep condition that requires proper evaluation and treatment with cognitive behavioral therapy for insomnia (CBT-I) as first-line therapy.

Understanding What's Happening

The evidence does not support aripiprazole causing permanent sleep changes years after discontinuation. While aripiprazole can cause insomnia during active treatment 1, and a single case report describes a discontinuation syndrome 2, there is no documented mechanism or evidence for persistent sleep disruption years after stopping the medication.

What the Evidence Shows About Aripiprazole and Sleep

During active treatment, aripiprazole commonly causes insomnia and restlessness 1, 3. In fact, recent research shows that among patients with schizophrenia, aripiprazole users experience more insomnia symptoms and poorer sleep quality compared to those on olanzapine or risperidone 4. One small study even found that low-dose aripiprazole reduced nocturnal sleep time by 1.3 hours 5.

After discontinuation, a 2024 randomized controlled trial specifically examined what happens when aripiprazole is stopped after achieving remission in depression. The study found no significant worsening of symptoms or emergence of new problems after discontinuation 6. Another discontinuation study of a different sleep medication (lemborexant) demonstrated that true medication-related sleep problems resolve within 2 weeks of stopping treatment 7.

The Real Issue: Chronic Insomnia Disorder

You likely have chronic insomnia disorder that either:

  • Existed before aripiprazole but was masked or partially treated by the medication
  • Developed independently during or after your treatment period
  • Was triggered by the original condition that led to aripiprazole prescription

Diagnostic Criteria to Consider

Chronic insomnia disorder requires 8:

  • Difficulty initiating or maintaining sleep, or early-morning awakening
  • Present at least 3 nights per week for at least 3 months
  • Causing clinically significant distress or functional impairment
  • Not attributable to another sleep, medical, or mental disorder

Evidence-Based Treatment Approach

First-Line Treatment: CBT-I

All patients with chronic insomnia should receive cognitive behavioral therapy for insomnia (CBT-I) as initial treatment 8, 9, 8. This is a strong recommendation based on moderate-quality evidence. CBT-I includes:

  • Cognitive therapy addressing distorted beliefs about sleep
  • Behavioral interventions including:
    • Sleep restriction therapy
    • Stimulus control (bed only for sleep/sex)
  • Sleep hygiene education

CBT-I can be delivered through multiple formats 8:

  • Individual or group therapy
  • Telephone-based modules
  • Web-based programs
  • Self-help books

Key point: CBT-I improves sleep onset latency, wake after sleep onset, sleep efficiency, and sleep quality with minimal harms 8.

Second-Line: Pharmacotherapy (If CBT-I Fails)

Only after unsuccessful CBT-I should you consider adding short-term pharmacotherapy through shared decision-making with your clinician 8. Options with evidence include:

Medications with moderate evidence:

  • Suvorexant (orexin antagonist)
  • Doxepin (low-dose)

Medications with low-quality evidence:

  • Eszopiclone
  • Zolpidem

Important FDA warnings 8:

  • Approved only for short-term use (4-5 weeks)
  • Associated with serious adverse effects including dementia, falls, fractures
  • Can cause daytime impairment, sleep-driving, behavioral abnormalities
  • Should not be continued for extended periods

Common Pitfalls to Avoid

  1. Attributing current symptoms to past medication use: Years after discontinuation, aripiprazole is not causing your sleep problems
  2. Seeking another medication first: This bypasses the most effective treatment (CBT-I) 8, 9
  3. Using over-the-counter sleep aids: Antihistamines and herbal supplements are not recommended due to lack of efficacy and safety data 10
  4. Accepting "this is just how I sleep now": Chronic insomnia is treatable with proper intervention

What You Should Do Now

  1. Seek formal evaluation for chronic insomnia disorder, including assessment for:

    • Secondary causes (depression, anxiety, medical conditions, substance use)
    • Other sleep disorders (sleep apnea, restless legs syndrome)
    • Medications that may worsen sleep
    • Poor sleep hygiene practices 10
  2. Pursue CBT-I as your primary treatment - this addresses the perpetuating factors maintaining your insomnia regardless of how it started

  3. If insomnia persists after adequate CBT-I trial, discuss short-term pharmacotherapy options with your clinician, understanding the risks and benefits 8

The evidence strongly indicates your current sleep problems represent a treatable chronic insomnia disorder requiring proper intervention, not a permanent consequence of past aripiprazole use.

References

Research

An aripiprazole discontinuation syndrome.

Rhode Island medical journal (2013), 2013

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.